Seagen
SGEN
#586
Rank
A$62.55 B
Marketcap
A$331.56
Share price
-0.07%
Change (1 day)
59.95%
Change (1 year)

Earnings for Seagen (SGEN)

Earnings in 2023 (TTM): -A$1.2 Billion

According to Seagen 's latest financial reports the company's current earnings are A$2.30 Billion. In 2022 the company made an earning of -A$0.89 Billion, an increase over its 2021 earnings that were of -A$0.99 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seagen from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$1.2 Billion34.26%
2022 -A$0.89 Billion-10.13%
2021 -A$0.99 Billion-214.28%
2020 A$0.86 B-370.63%
2019 -A$0.32 Billion-15.17%
2018 -A$0.38 Billion32.79%
2017 -A$0.29 Billion37.19%
2016 -A$0.21 Billion18%
2015 -A$0.18 Billion56.34%
2014 -A$0.12 Billion23.07%
2013 -A$91.12 Million
2011 -A$0.21 Billion111.72%
2010 -A$98.86 Million-19.63%
2009 -A$0.13 Billion-7.55%
2008 -A$0.14 Billion64.95%
2007 -A$80.66 Million38.4%
2006 -A$58.28 Million25.36%
2005 -A$46.49 Million-14.86%
2004 -A$54.6 Million61.92%
2003 -A$33.72 Million-7.67%
2002 -A$36.53 Million6.76%
2001 -A$34.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$15.35 B-1,439.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$9.56 B-934.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.35 B-305.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.91 B-1,313.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.51 B-1,366.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-A$89.7 Million-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-A$91 Million-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.42 Billion-63.65%๐Ÿ‡บ๐Ÿ‡ธ USA